Showing results (1231-1240 of 2,812) with videos related to
Sort By:
Pageof 282
Expert Opinion on Drug Safety|September 9, 2014
Psychotropic drugs and bruxismGiovanni Falisi, Claudio Rastelli, Fabrizio Panti, et al.Expert Opinion on Drug Safety|October 14, 2014
Antihistamines and birth defects: a systematic review of the literatureSuzanne M Gilboa, Elizabeth C Ailes, Ramona P Rai, et al.Expert Opinion on Drug Safety|October 25, 2014
Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillationMikhail S Dzeshka, Gregory Yh LipExpert Opinion on Drug Safety|February 9, 2018
The launch of opicapone for Parkinson's disease: negatives versus positivesAna Castro Caldas, Tiago Teodoro, Joaquim J FerreiraExpert Opinion on Drug Safety|January 16, 2018
The safety of available treatments of male hypogonadism in organic and functional hypogonadismG Corona, G Rastrelli, Y Reisman, et al.Expert Opinion on Drug Safety|December 8, 2017
New and incremental FDA black box warnings from 2008 to 2015Michael T Solotke, Sanket S Dhruva, Nicholas S Downing, et al.Expert Opinion on Drug Safety|January 12, 2018
The cardiovascular effect of incretin-based therapies among type 2 diabetes: a systematic review and network meta-analysisShanshan Wu, Andrea Cipriani, Zhirong Yang, et al.Expert Opinion on Drug Safety|December 6, 2017
Therapeutic drug monitoring of anti-TNF therapy in children with inflammatory bowel diseaseKaren van Hoeve, Ilse Hoffman, Severine VermeireExpert Opinion on Drug Safety|March 1, 2018
Safety of humanized monoclonal antibodies against IL-5 in asthma: focus on reslizumabMario Cazzola, Maria Gabriella Matera, Francesca Levi-Schaffer, et al.Expert Opinion on Drug Safety|March 6, 2018
Safety of treatment options for spondyloarthritis: a narrative reviewSalvatore D'Angelo, Antonio Carriero, Michele Gilio, et al.Pageof 282